Post date March 4, 2024 Experience Fiserv $2 billion notes offering The investment-grade debt consists of three tranches of notes
Post date February 5, 2024 Experience Novo Nordisk acquisition of certain Catalent sites from Novo Holdings We are advising Novo Nordisk on the acquisition
Post date December 21, 2023 Experience GSK exclusive license agreement for HS-20093 with Hansoh Pharma We advised GSK on the transaction
Post date October 31, 2023 Experience GSK exclusive license agreement for HS-20089 with Hansoh Pharma We advised GSK on the transaction
Post date October 30, 2023 Experience GSK collaboration extension and new data licensing agreement with 23andMe We advised GSK on the transaction
Post date August 22, 2023 Experience Fiserv $2 billion notes offering The investment-grade debt consists of two tranches of notes
Post date July 28, 2023 Experience BMS $35 million investment in Immatics We advised Immatics on the private placement of ordinary shares
Post date June 28, 2023 Experience Centogene strategic collaboration with Lifera We are advising Centogene on its joint venture with and convertible debt investment by Lifera
Post date May 24, 2023 Experience Fiserv €800 million notes offering The investment-grade notes are due 2031
Post date May 12, 2023 Experience GSK exclusive licensing agreement with Scynexis We advised GSK on the transaction